advanced health and care limited Company Information
Company Number
02939302
Next Accounts
Nov 2025
Shareholders
drury lane (jersey) ltd
Group Structure
View All
Industry
Computer consultancy activities
Registered Address
the mailbox level 3, 101 wharfside street, birmingham, B1 1RF
Website
www.oneadvanced.comadvanced health and care limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED HEALTH AND CARE LIMITED at £50.3m based on a Turnover of £33.1m and 1.52x industry multiple (adjusted for size and gross margin).
advanced health and care limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED HEALTH AND CARE LIMITED at £0 based on an EBITDA of £-418k and a 10.71x industry multiple (adjusted for size and gross margin).
advanced health and care limited Estimated Valuation
Pomanda estimates the enterprise value of ADVANCED HEALTH AND CARE LIMITED at £34.4m based on Net Assets of £15m and 2.29x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Advanced Health And Care Limited Overview
Advanced Health And Care Limited is a live company located in birmingham, B1 1RF with a Companies House number of 02939302. It operates in the information technology consultancy activities sector, SIC Code 62020. Founded in June 1994, it's largest shareholder is drury lane (jersey) ltd with a 100% stake. Advanced Health And Care Limited is a mature, large sized company, Pomanda has estimated its turnover at £33.1m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Advanced Health And Care Limited Health Check
Pomanda's financial health check has awarded Advanced Health And Care Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs


4 Strong

3 Regular

4 Weak

Size
annual sales of £33.1m, make it larger than the average company (£1.3m)
£33.1m - Advanced Health And Care Limited
£1.3m - Industry AVG

Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (9.2%)
-4% - Advanced Health And Care Limited
9.2% - Industry AVG

Production
with a gross margin of 68%, this company has a lower cost of product (45.9%)
68% - Advanced Health And Care Limited
45.9% - Industry AVG

Profitability
an operating margin of -1.9% make it less profitable than the average company (6.2%)
-1.9% - Advanced Health And Care Limited
6.2% - Industry AVG

Employees
with 256 employees, this is above the industry average (11)
- Advanced Health And Care Limited
11 - Industry AVG

Pay Structure
on an average salary of £53.3k, the company has an equivalent pay structure (£59k)
- Advanced Health And Care Limited
£59k - Industry AVG

Efficiency
resulting in sales per employee of £129.2k, this is equally as efficient (£129.2k)
- Advanced Health And Care Limited
£129.2k - Industry AVG

Debtor Days
it gets paid by customers after 63 days, this is near the average (61 days)
63 days - Advanced Health And Care Limited
61 days - Industry AVG

Creditor Days
its suppliers are paid after 73 days, this is slower than average (27 days)
73 days - Advanced Health And Care Limited
27 days - Industry AVG

Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Advanced Health And Care Limited
- - Industry AVG

Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (17 weeks)
0 weeks - Advanced Health And Care Limited
17 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 89.9%, this is a higher level of debt than the average (55.8%)
89.9% - Advanced Health And Care Limited
55.8% - Industry AVG
ADVANCED HEALTH AND CARE LIMITED financials

Advanced Health And Care Limited's latest turnover from February 2024 is £33.1 million and the company has net assets of £15 million. According to their latest financial statements, we estimate that Advanced Health And Care Limited has 256 employees and maintains cash reserves of £2.2 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 33,069,000 | 28,516,000 | 35,446,000 | 36,831,000 | 32,098,000 | 29,982,000 | 30,374,000 | 31,189,000 | 33,330,000 | 32,815,000 | 30,864,000 | 25,742,000 | 22,656,000 | 14,976,000 | 14,278,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 10,600,000 | 9,298,000 | 9,243,000 | 8,151,000 | 8,719,000 | 8,648,000 | 8,932,000 | 10,974,000 | 14,027,000 | 12,121,000 | 11,366,000 | 10,129,000 | 8,141,000 | 5,533,000 | 5,180,000 |
Gross Profit | 22,469,000 | 19,218,000 | 26,203,000 | 28,680,000 | 23,379,000 | 21,334,000 | 21,442,000 | 20,215,000 | 19,303,000 | 20,694,000 | 19,498,000 | 15,613,000 | 14,515,000 | 9,443,000 | 9,098,000 |
Admin Expenses | 23,100,000 | 30,397,000 | 8,305,000 | 7,938,000 | 8,291,000 | 9,949,000 | 11,614,000 | 11,340,000 | 16,946,000 | 15,194,000 | 12,671,000 | 10,205,000 | 10,264,000 | 3,983,000 | 4,157,000 |
Operating Profit | -631,000 | -11,179,000 | 17,898,000 | 20,742,000 | 15,088,000 | 11,385,000 | 9,828,000 | 8,875,000 | 2,357,000 | 5,500,000 | 6,827,000 | 5,408,000 | 4,251,000 | 5,460,000 | 4,941,000 |
Interest Payable | 6,284,000 | 4,712,000 | 3,033,000 | 2,643,000 | 2,865,000 | 1,385,000 | 26,000 | 24,000 | 6,000 | 23,000 | 16,000 | 21,000 | 8,000 | 10,000 | 26,000 |
Interest Receivable | 2,844,000 | 2,132,000 | 1,472,000 | 5,565,000 | 1,108,000 | 1,156,000 | 969,000 | 971,000 | 1,003,000 | 870,000 | 645,000 | 451,000 | 1,000 | 1,000 | 157,000 |
Pre-Tax Profit | -4,071,000 | -13,759,000 | 16,337,000 | 23,664,000 | 13,331,000 | 11,156,000 | 10,771,000 | 9,822,000 | 3,354,000 | 6,347,000 | 7,456,000 | 5,838,000 | 4,244,000 | 5,451,000 | 5,072,000 |
Tax | -622,000 | 1,392,000 | -3,743,000 | -1,292,000 | 2,024,000 | -919,000 | -4,203,000 | 814,000 | 430,000 | -319,000 | -1,953,000 | -623,000 | -1,391,000 | -1,285,000 | -1,540,000 |
Profit After Tax | -4,693,000 | -12,367,000 | 12,594,000 | 22,372,000 | 15,355,000 | 10,237,000 | 6,568,000 | 10,636,000 | 3,784,000 | 6,028,000 | 5,503,000 | 5,215,000 | 2,853,000 | 4,166,000 | 3,532,000 |
Dividends Paid | 8,000,000 | ||||||||||||||
Retained Profit | -4,693,000 | -12,367,000 | 12,594,000 | 22,372,000 | 15,355,000 | 10,237,000 | 6,568,000 | 10,636,000 | 3,784,000 | 6,028,000 | -2,497,000 | 5,215,000 | 2,853,000 | 4,166,000 | 3,532,000 |
Employee Costs | 13,633,000 | 12,850,000 | 11,869,000 | 11,988,000 | 11,585,000 | 10,667,000 | 10,571,000 | 12,858,000 | 15,523,000 | 14,671,000 | 12,799,000 | 11,289,000 | 10,433,000 | 5,914,000 | 5,030,000 |
Number Of Employees | 18 | 209 | 212 | 209 | 218 | 273 | 299 | 284 | 254 | 217 | 215 | 140 | 133 | ||
EBITDA* | -418,000 | -11,032,000 | 18,106,000 | 20,967,000 | 15,412,000 | 12,185,000 | 11,335,000 | 10,286,000 | 5,355,000 | 8,212,000 | 9,165,000 | 7,234,000 | 4,368,000 | 5,631,000 | 5,119,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 268,000 | 532,000 | 324,000 | 338,000 | 471,000 | 745,000 | 1,258,000 | 1,955,000 | 1,849,000 | 1,708,000 | 962,000 | 701,000 | 355,000 | 340,000 | 386,000 |
Intangible Assets | 200,000 | 846,000 | 1,485,000 | 3,735,000 | 5,982,000 | 6,723,000 | 6,453,000 | 8,088,000 | |||||||
Investments & Other | 56,319,000 | 127,918,000 | 127,918,000 | 105,117,000 | 105,117,000 | 105,117,000 | |||||||||
Debtors (Due After 1 year) | 247,000 | 543,000 | 469,000 | ||||||||||||
Total Fixed Assets | 56,834,000 | 128,993,000 | 128,711,000 | 105,455,000 | 105,588,000 | 105,862,000 | 1,458,000 | 2,801,000 | 3,334,000 | 5,443,000 | 6,944,000 | 7,424,000 | 6,808,000 | 8,428,000 | 386,000 |
Stock & work in progress | 202,000 | 188,000 | 164,000 | 179,000 | 244,000 | 403,000 | 244,000 | 309,000 | 219,000 | 121,000 | 106,000 | ||||
Trade Debtors | 5,737,000 | 12,190,000 | 8,104,000 | 8,461,000 | 8,398,000 | 9,862,000 | 11,468,000 | 7,485,000 | 6,174,000 | 6,856,000 | 5,513,000 | 5,204,000 | 4,377,000 | 4,658,000 | 2,279,000 |
Group Debtors | 81,554,000 | 73,637,000 | 71,279,000 | 61,570,000 | 31,038,000 | 29,599,000 | 46,003,000 | 34,226,000 | 26,492,000 | 20,948,000 | 17,152,000 | 11,681,000 | 13,682,000 | 7,850,000 | 8,249,000 |
Misc Debtors | 2,521,000 | 3,849,000 | 2,239,000 | 1,090,000 | 3,098,000 | 3,709,000 | 4,100,000 | 4,858,000 | 5,049,000 | 3,360,000 | 3,286,000 | 2,177,000 | 1,217,000 | 806,000 | 341,000 |
Cash | 2,150,000 | 3,215,000 | 1,359,000 | 854,000 | 1,571,000 | 1,934,000 | 850,000 | 2,882,000 | 1,538,000 | 2,019,000 | 3,131,000 | 9,263,000 | 1,138,000 | 3,723,000 | 468,000 |
misc current assets | |||||||||||||||
total current assets | 91,962,000 | 92,891,000 | 82,981,000 | 71,975,000 | 44,307,000 | 45,292,000 | 62,585,000 | 49,630,000 | 39,497,000 | 33,586,000 | 29,326,000 | 28,634,000 | 20,633,000 | 17,158,000 | 11,443,000 |
total assets | 148,796,000 | 221,884,000 | 211,692,000 | 177,430,000 | 149,895,000 | 151,154,000 | 64,043,000 | 52,431,000 | 42,831,000 | 39,029,000 | 36,270,000 | 36,058,000 | 27,441,000 | 25,586,000 | 11,829,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 2,142,000 | 3,148,000 | 945,000 | 312,000 | 770,000 | 493,000 | 593,000 | 482,000 | 1,979,000 | 632,000 | 595,000 | 951,000 | 484,000 | 458,000 | 258,000 |
Group/Directors Accounts | 113,022,000 | 107,634,000 | 100,589,000 | 73,937,000 | 71,167,000 | 86,572,000 | 4,723,000 | 5,042,000 | 4,525,000 | 5,380,000 | 6,640,000 | 7,223,000 | 7,326,000 | 8,256,000 | 1,206,000 |
other short term finances | |||||||||||||||
hp & lease commitments | 13,000 | 61,000 | 136,000 | 136,000 | 102,000 | 67,000 | |||||||||
other current liabilities | 5,016,000 | 16,245,000 | 5,850,000 | 11,244,000 | 8,729,000 | 10,406,000 | 15,268,000 | 9,955,000 | 9,898,000 | 10,196,000 | 12,278,000 | 7,829,000 | 5,317,000 | 5,513,000 | 3,427,000 |
total current liabilities | 120,180,000 | 127,027,000 | 107,384,000 | 85,493,000 | 80,666,000 | 97,471,000 | 20,597,000 | 15,540,000 | 16,538,000 | 16,344,000 | 19,615,000 | 16,070,000 | 13,127,000 | 14,227,000 | 4,891,000 |
loans | |||||||||||||||
hp & lease commitments | 13,000 | 74,000 | 208,000 | 255,000 | 200,000 | ||||||||||
Accruals and Deferred Income | 836,000 | 479,000 | 304,000 | 527,000 | 191,000 | ||||||||||
other liabilities | |||||||||||||||
provisions | 12,735,000 | 3,041,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 300,000 | 277,000 | 319,000 | 270,000 | 357,000 | 375,000 | 543,000 | 403,000 |
total long term liabilities | 13,571,000 | 3,520,000 | 604,000 | 827,000 | 491,000 | 300,000 | 300,000 | 313,000 | 351,000 | 527,000 | 525,000 | 557,000 | 375,000 | 543,000 | 403,000 |
total liabilities | 133,751,000 | 130,547,000 | 107,988,000 | 86,320,000 | 81,157,000 | 97,771,000 | 20,897,000 | 15,853,000 | 16,889,000 | 16,871,000 | 20,140,000 | 16,627,000 | 13,502,000 | 14,770,000 | 5,294,000 |
net assets | 15,045,000 | 91,337,000 | 103,704,000 | 91,110,000 | 68,738,000 | 53,383,000 | 43,146,000 | 36,578,000 | 25,942,000 | 22,158,000 | 16,130,000 | 19,431,000 | 13,939,000 | 10,816,000 | 6,535,000 |
total shareholders funds | 15,045,000 | 91,337,000 | 103,704,000 | 91,110,000 | 68,738,000 | 53,383,000 | 43,146,000 | 36,578,000 | 25,942,000 | 22,158,000 | 16,130,000 | 19,431,000 | 13,939,000 | 10,816,000 | 6,535,000 |
Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 | Feb 2019 | Feb 2018 | Feb 2017 | Feb 2016 | Feb 2015 | Feb 2014 | Feb 2013 | Feb 2012 | Feb 2011 | Feb 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | -631,000 | -11,179,000 | 17,898,000 | 20,742,000 | 15,088,000 | 11,385,000 | 9,828,000 | 8,875,000 | 2,357,000 | 5,500,000 | 6,827,000 | 5,408,000 | 4,251,000 | 5,460,000 | 4,941,000 |
Depreciation | 213,000 | 147,000 | 208,000 | 225,000 | 324,000 | 600,000 | 861,000 | 772,000 | 773,000 | 465,000 | 270,000 | 192,000 | 117,000 | 171,000 | 178,000 |
Amortisation | 200,000 | 646,000 | 639,000 | 2,225,000 | 2,247,000 | 2,068,000 | 1,634,000 | ||||||||
Tax | -622,000 | 1,392,000 | -3,743,000 | -1,292,000 | 2,024,000 | -919,000 | -4,203,000 | 814,000 | 430,000 | -319,000 | -1,953,000 | -623,000 | -1,391,000 | -1,285,000 | -1,540,000 |
Stock | -202,000 | 14,000 | 24,000 | -15,000 | -65,000 | -159,000 | 159,000 | -65,000 | 90,000 | 98,000 | 15,000 | 106,000 | |||
Debtors | -160,000 | 8,128,000 | 10,970,000 | 28,587,000 | -636,000 | -18,401,000 | 15,002,000 | 8,854,000 | 6,551,000 | 5,213,000 | 6,889,000 | -214,000 | 5,962,000 | 2,445,000 | 10,869,000 |
Creditors | -1,006,000 | 2,203,000 | 633,000 | -458,000 | 277,000 | -100,000 | 111,000 | -1,497,000 | 1,347,000 | 37,000 | -356,000 | 467,000 | 26,000 | 200,000 | 258,000 |
Accruals and Deferred Income | -10,872,000 | 10,570,000 | -5,617,000 | 2,851,000 | -1,486,000 | -4,862,000 | 5,313,000 | 57,000 | -298,000 | -2,082,000 | 4,449,000 | 2,512,000 | -196,000 | 2,086,000 | 3,427,000 |
Deferred Taxes & Provisions | 9,694,000 | 2,741,000 | 23,000 | -42,000 | 49,000 | -87,000 | -18,000 | -168,000 | 140,000 | 403,000 | |||||
Cash flow from operations | -3,064,000 | -2,254,000 | -1,591,000 | -6,317,000 | 16,849,000 | 24,681,000 | -2,431,000 | 894,000 | 400,000 | 525,000 | 4,394,000 | 9,696,000 | -3,421,000 | 4,312,000 | -3,308,000 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | -71,599,000 | 22,801,000 | 105,117,000 | ||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 5,388,000 | 7,045,000 | 26,652,000 | 2,770,000 | -15,405,000 | 81,849,000 | -319,000 | 517,000 | -855,000 | -1,260,000 | -583,000 | -103,000 | -930,000 | 7,050,000 | 1,206,000 |
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | -13,000 | -61,000 | -136,000 | -134,000 | -13,000 | 90,000 | 267,000 | ||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -3,440,000 | -2,580,000 | -1,561,000 | 2,922,000 | -1,757,000 | -229,000 | 943,000 | 947,000 | 997,000 | 847,000 | 629,000 | 430,000 | -7,000 | -9,000 | 131,000 |
cash flow from financing | -69,651,000 | 4,465,000 | 25,091,000 | 5,692,000 | -17,162,000 | 81,607,000 | 563,000 | 1,328,000 | 8,000 | -426,000 | -668,000 | 871,000 | -667,000 | 7,156,000 | 4,340,000 |
cash and cash equivalents | |||||||||||||||
cash | -1,065,000 | 1,856,000 | 505,000 | -717,000 | -363,000 | 1,084,000 | -2,032,000 | 1,344,000 | -481,000 | -1,112,000 | -6,132,000 | 8,125,000 | -2,585,000 | 3,255,000 | 468,000 |
overdraft | |||||||||||||||
change in cash | -1,065,000 | 1,856,000 | 505,000 | -717,000 | -363,000 | 1,084,000 | -2,032,000 | 1,344,000 | -481,000 | -1,112,000 | -6,132,000 | 8,125,000 | -2,585,000 | 3,255,000 | 468,000 |
advanced health and care limited Credit Report and Business Information
Advanced Health And Care Limited Competitor Analysis

Perform a competitor analysis for advanced health and care limited by selecting its closest rivals, whether from the INFORMATION AND COMMUNICATION sector, other large companies, companies in B 1 area or any other competitors across 12 key performance metrics.
advanced health and care limited Ownership
ADVANCED HEALTH AND CARE LIMITED group structure
Advanced Health And Care Limited has 2 subsidiary companies.
Ultimate parent company
ASTON MIDCO LTD
#0138454
DRURY LANE (JERSEY) LTD
#0036454
2 parents
ADVANCED HEALTH AND CARE LIMITED
02939302
2 subsidiaries
advanced health and care limited directors
Advanced Health And Care Limited currently has 2 directors. The longest serving directors include Mr Stephen Dews (Jun 2023) and Mr Simon Walsh (Jun 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Stephen Dews | United Kingdom | 49 years | Jun 2023 | - | Director |
Mr Simon Walsh | United Kingdom | 53 years | Jun 2023 | - | Director |
P&L
February 2024turnover
33.1m
+16%
operating profit
-631k
-94%
gross margin
68%
+0.82%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
February 2024net assets
15m
-0.84%
total assets
148.8m
-0.33%
cash
2.2m
-0.33%
net assets
Total assets minus all liabilities
advanced health and care limited company details
company number
02939302
Type
Private limited with Share Capital
industry
62020 - Computer consultancy activities
incorporation date
June 1994
age
31
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
February 2024
previous names
adastra software limited (February 2011)
adastra software limited (October 2009)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
the mailbox level 3, 101 wharfside street, birmingham, B1 1RF
Bank
-
Legal Advisor
-
advanced health and care limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 9 charges/mortgages relating to advanced health and care limited. Currently there are 1 open charges and 8 have been satisfied in the past.
advanced health and care limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ADVANCED HEALTH AND CARE LIMITED. This can take several minutes, an email will notify you when this has completed.
advanced health and care limited Companies House Filings - See Documents
date | description | view/download |
---|